Arguments for and against Germline Intervention: A Critical Review of Ronald Green’s Babies by Design

Journal of Healthcare Ethics and Administration 3 (1) (2017)
  Copy   BIBTEX


It seems certain that one day we will allow the genetic technology which will enhance our offspring. A highly effective new tool, called CRISPR, which allows for carving out genes, is already being used to edit the genomes of animals. In July 2017, the FDA legalized that germline drugs for therapeutic purposes could be sold in the market. It is a high time, now, that we need engage in discussions about the ethics of germline intervention. To contribute to the discussion by showing our thought and to educate the public, we write this paper.

Author's Profile

Marvin Lee
La Salle University


Added to PP

465 (#24,244)

6 months
33 (#59,883)

Historical graph of downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.
How can I increase my downloads?